{"entity":{"id":"gupta-sudeep","kind":"person","name":"Sudeep Gupta","aka":[],"tldr":"Sudeep Gupta leads India's largest cancer centre and its programme of pragmatic, affordable trials.","summary":"Sudeep Gupta is Director of the Tata Memorial Centre in Mumbai, India's largest cancer centre, and Professor of Medical Oncology. A breast and gynaecologic medical oncologist, he leads the centre's programme of pragmatic, affordable trials, randomised studies designed for resource-limited settings that reach tens of thousands of new patients a year. His publications include the randomised trial of locoregional treatment of the primary tumour in metastatic breast cancer and the trial of peritumoral infiltration of local anaesthetic before surgery in early breast cancer. His interests span HR-positive, triple-negative and ovarian cancer, clinical trials and global oncology.","asOf":"2026-09-08","wikipedia":"https://en.wikipedia.org/wiki/Sudeep_Gupta","links":[{"label":"Tata Memorial Centre","url":"https://tmc.gov.in"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gupta%20S%5BAuthor%5D%20Tata%20Memorial%20breast%20cancer"}],"tags":[],"related":[],"cancers":["breast-hr-positive","tnbc","ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["tata-memorial"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director, Tata Memorial Centre; Professor of Medical Oncology","institutionId":"tata-memorial","specialisms":["Breast cancer","Gynaecologic oncology","Clinical trials","Global oncology"],"profiles":[{"label":"Tata Memorial Centre","url":"https://tmc.gov.in"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gupta%20S%5BAuthor%5D%20Tata%20Memorial%20breast%20cancer"}],"papers":[{"title":"Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial","journal":"The Lancet Oncology","year":2015,"doi":"10.1016/s1470-2045(15)00135-7"},{"title":"Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer","journal":"Journal of Clinical Oncology","year":2023,"doi":"10.1200/jco.22.01966"}],"orcid":"0000-0002-6742-6378"},"route":"/people/gupta-sudeep/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"institution":[{"id":"actrec","kind":"institution","name":"Advanced Centre for Treatment, Research and Education in Cancer","route":"/institutions/actrec/"},{"id":"national-cancer-grid","kind":"institution","name":"National Cancer Grid of India","route":"/institutions/national-cancer-grid/"},{"id":"tata-memorial","kind":"institution","name":"Tata Memorial Centre","route":"/institutions/tata-memorial/"}],"idea":[{"id":"idea-bio2-low-dose-olanzapine-appetite","kind":"idea","name":"A cheap old tablet to restore appetite","route":"/ideas/idea-bio2-low-dose-olanzapine-appetite/"},{"id":"idea-fund-lmic-burden-match","kind":"idea","name":"Burden-matched funding for trials led in low- and middle-income countries","route":"/ideas/idea-fund-lmic-burden-match/"},{"id":"idea-tr1-lmic-sites-in-pivotal-trials","kind":"idea","name":"Pivotal trials include sites in Africa, South Asia and Latin America, sponsor-funded","route":"/ideas/idea-tr1-lmic-sites-in-pivotal-trials/"}],"technology":[{"id":"cachexia-appetite-pharmacotherapy","kind":"technology","name":"Cachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine","route":"/technologies/cachexia-appetite-pharmacotherapy/"}],"trial":[{"id":"olanzapine-appetite-tmh","kind":"trial","name":"Low-dose olanzapine for cancer anorexia (Tata Memorial)","route":"/trials/olanzapine-appetite-tmh/"}]}}